| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 05/10/2002 | CA2427568A1 Tricyclic derivatives of indole with antiangiogenic activity |
| 05/10/2002 | CA2427565A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 05/09/2002 | US20020055510 Useful in the treatment of cancer. |
| 05/09/2002 | US20020055502 New compounds, their preparation and use |
| 05/09/2002 | US20020055045 Novel materials useful as electrolytic solutes |
| 05/09/2002 | US20020054899 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 05/08/2002 | EP1203771A1 Remedies or preventives for frequent urination or urinary incontinence |
| 05/08/2002 | EP1203091A1 Chemiluminescent substrates of hydrolytic enzymes such as phosphatases |
| 05/08/2002 | EP1202994A1 New compounds |
| 05/08/2002 | EP1202985A2 Chemokine receptor antagonists |
| 05/08/2002 | EP1202976A1 Pyrazinones, compositions containing such compounds |
| 05/08/2002 | EP1202971A2 Pharmaceutical compositions comprising 4-quinolones |
| 05/08/2002 | EP1202964A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 05/08/2002 | EP1202627A2 Fungicidal combinations of active substances |
| 05/08/2002 | EP1202626A1 Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
| 05/08/2002 | EP0723545B1 Quinolizinone type compounds |
| 05/08/2002 | DE10054932A1 Antiviral medicaments containing new or known chroman-4-one or chroman-4-one derivatives, especially effective against hepatitis B virus infections |
| 05/08/2002 | CN1348370A Cyclic protein tyrosine kinase inhibitors |
| 05/08/2002 | CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor |
| 05/08/2002 | CN1347875A Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound |
| 05/07/2002 | US6384050 Tricyclic amine derivatives |
| 05/07/2002 | US6384045 Tricyclic and tetracyclic pyrones |
| 05/07/2002 | CA2216535C Protein kinase c inhibitors |
| 05/07/2002 | CA2145000C Compounds which are selective antagonists of the human nk3 receptor and their use as medicinal products and diagnostic tools |
| 05/02/2002 | WO2002034760A2 Compounds and methods |
| 05/02/2002 | WO2002034749A1 Polysubstituted imidazopyridines as gastric secretion inhibitors |
| 05/02/2002 | WO2002034745A1 Chemokine receptor binding heterocyclic compounds |
| 05/02/2002 | WO2002034716A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | WO2002014324A3 Diazepinones as antiviral agents |
| 05/02/2002 | WO2002014323A3 Polymorphs of an epothilone analog |
| 05/02/2002 | WO2001023375A3 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/02/2002 | US20020052501 Useful in photochemical polymerization, dye lasers, and electroluminescent elements |
| 05/02/2002 | US20020052500 Reacting perylene-3,4,9,10-tetracarboximide or derivatives with formaldehyde to form bis(hydroxymethyl)perylene-3,4,9,10-tetracarboximide, which further reacts with a precursor of organic redicals |
| 05/02/2002 | US20020052499 Photochromic naphthopyrans |
| 05/02/2002 | US20020052495 Pyramidine or triazine derivatives which specifically inhibit the binding of endothelin to the receptor |
| 05/02/2002 | US20020052398 Pharmaceutical composition of 6-amino EM-12 |
| 05/02/2002 | US20020052384 Furopyrimidines and pyrrolopyrimidines; treating cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in immunocompromised patients. |
| 05/02/2002 | US20020052372 Using neurotrophic pipecolic acid derivative compounds having an affinity for FKBP-type immunophilins as inhibitors of the enzyme activity associated with immunophilin proteins |
| 05/02/2002 | US20020052371 Neuropeptide Y receptor antagonist; treatment of bulimia, obesity or diabetes; e.g., spiro(isobenzofuran-1-(3H),4'-pyridine)-1'-carboxamides |
| 05/02/2002 | US20020052364 Condensed 2,3-benzodiazepine derivatives and their use as AMPA-receptor inhibitors |
| 05/02/2002 | EP1200443A1 Aromatic esters of camptothecins and methods to treat cancers |
| 05/02/2002 | EP1200442A1 2,3-benzodiazepine derivatives |
| 05/02/2002 | EP1200410A1 Isoquinoline derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the active substance |
| 05/02/2002 | EP1200089A1 Pyridomorphinans and use thereof |
| 05/02/2002 | EP1200068A2 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 05/02/2002 | EP0888359B1 Pyrimidin-4-one derivatives as pesticide |
| 05/02/2002 | EP0765336B1 Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides |
| 05/02/2002 | CA2426616A1 Polysubstituted imidazopyridines as gastric secretion inhibitors |
| 05/02/2002 | CA2425288A1 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | CA2421796A1 Chemokine receptor binding heterocyclic compounds |
| 05/01/2002 | CN1347414A Triazole compounds with dopamine-D3-receptor affinity |
| 05/01/2002 | CN1346826A Microbicidal halobenzoimidazole, composition and process for preparing same |
| 05/01/2002 | CN1083843C 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano [2,3-e] indol-8-ones and derivs., and pharmaceutical compositions thereof |
| 04/30/2002 | USRE37686 Biosynthesis of polypeptides |
| 04/30/2002 | US6380395 Anticancer agents |
| 04/30/2002 | US6380384 Anxiolytic agents |
| 04/30/2002 | US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 04/30/2002 | US6380246 For combating pests and weeds |
| 04/30/2002 | US6380225 Microbicidal benzotriazoles |
| 04/30/2002 | US6380211 For treating diabetes |
| 04/30/2002 | US6380207 1h-(1)benzopyrano(3,4-f) quinoline derivatives |
| 04/30/2002 | US6380204 Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist activity |
| 04/30/2002 | US6379591 Naphthopyrans annelated in C5-C6 with a lactam-type C6 ring and compositions and (co)polymer matrices containing them |
| 04/25/2002 | WO2002032904A1 New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents |
| 04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 04/25/2002 | WO2002032891A1 Flavan compounds, their preparation and their use in therapy |
| 04/25/2002 | WO2002032872A1 Nitrogenous aromatic ring compounds |
| 04/25/2002 | WO2002032422A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | WO2001002369A3 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 04/25/2002 | US20020049327 Such as 7-(3-chlorophenyl)-9-((4-chlorophenyl)-1H-imidazol-1-ylmethyl)-2,3-dihydro -1H,5H-benzo(ij)quinolizin-5-one; for forming oncogenes for signalling transformation of tumor cells |
| 04/25/2002 | US20020049324 Topoisomerase inhibitors |
| 04/25/2002 | US20020049323 Anxiolytic agents |
| 04/25/2002 | US20020049322 Quinoline and quinazoline compounds useful in therapy |
| 04/25/2002 | US20020049235 Pyridylpyrrole compounds useful as interleukin-and tnf antagonists |
| 04/25/2002 | US20020049231 S(-)-3-aminothalidomide; treating wide variety of diseases including diabetic retinopathy |
| 04/25/2002 | US20020049222 Cyclopentyl modulators of chemokine receptor activity |
| 04/25/2002 | US20020049203 CRF receptor antagonists and methods relating thereto |
| 04/25/2002 | US20020049195 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc. |
| 04/25/2002 | US20020049154 Bioconjugates and delivery of bioactive agents |
| 04/25/2002 | CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | CA2426103A1 New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents |
| 04/24/2002 | EP1199304A1 Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders |
| 04/24/2002 | EP1198465A1 Process for the preparation of 1,8-disubstituted-1,3,4,9-tetrahydropyrano (3,4-b)-indole-1-acetic acid esters in a hydroxylic solvent |
| 04/24/2002 | CN1346348A Amide compounds and medicinal use thereof |
| 04/24/2002 | CN1083453C Fused imidazole derivatives as emultidrug resistance modulators |
| 04/24/2002 | CN1083430C Carbazolone derivatives |
| 04/23/2002 | US6376676 Intermediates in the synthesis of (±)-camptothecin and related compounds and synthesis thereof |
| 04/23/2002 | US6376670 Bactericide for grampositive bacteria |
| 04/23/2002 | US6376584 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith |
| 04/23/2002 | US6376521 A3 adenosine receptor antagonists |
| 04/23/2002 | US6376516 Noscapine and noscapine derivatives, useful as anticancer agents |
| 04/23/2002 | US6376505 Novel serotonin receptor antagonists; substituted aryloxy-2-ol-3-(4-spiro-(alkanedioxy)isobenzofuranyl- and phthaloyl 1-piperidine) derivatives; useful in treating anxiety, depression, and nicotine withdrawal |
| 04/23/2002 | US6376503 Alpha 1a adrenergic receptor antagonists |
| 04/18/2002 | WO2002030936A1 Pyrrole-condensed morphinoid derivatives |
| 04/18/2002 | WO2002030935A1 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/18/2002 | WO2002030908A1 Inhibitors of protein kinases |
| 04/18/2002 | WO2002030895A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-η BINDING AGENTS |
| 04/18/2002 | WO2002030890A1 Nitrogenous five-membered ring compounds |
| 04/18/2002 | WO2002030455A2 Agents for the treatment of viral infections |
| 04/18/2002 | WO2001064681A3 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |